|
| 12.00 a.m. |
Start of Registration (Hotel Regent) |
BDA Immunotherapy Working Group
(closed meeting):
Improving the effiacy of cancer Immunotherapy
What do we need to know? What can we measure?
A critical evaluation of currently determined immune parametres
This meeting is only for particular members of the BDA Immunotherapy
Working Group. However we offer the possibility for a limited
number of interested scientists to take part. If you are interested
to join the meeting please enquire although we reserve the right
to pre-elect. |
| 1.00 - 1.20 p.m. |
Welcome and Introduction
Chair: L. Hakansson, S. Khleif
|
1.00 - 1.20
1.20 - 2.35 p.m.
1.20 - 1.45 p.m.
1.45 - 2.10 p.m.
2.10 - 2.35 p.m. |
What do we need to know to improve the efficacy of
immunotherapy ?
L. Håkansson
Overview
Camouflage and sabotage: Tumour escape from immune
surveillance
R. Kiessling, Stockholm
Active immunotherapy of cancer – operational and biologic
challenges to making it work
L. Finke, Durham
Predicting responders to immunotherapy by intensive
immunomonitoring
H. Singh, Tübingen |
| 2.35 - 3.00 p.m. |
Coffee Break |
| 3:00 - 6:00 p.m. |
Monitoring immunotherapy
Chair: A. Hoos, C. Zielinski |
3.00 - 3.25 p.m.
3.25 - 3.50 p.m.
3.50 - 4.15
4.15 - 4.40 p.m.
4.40 p.m. 5.05 p.m.
5.05 - 5.30
5.30 - 6.00 |
T-helper responses and establishment of long term
memory responses following vaccination with K-ras
and telomerase vaccines
G.Gaudernack
Monitoring the immunological responses to NY-ESO-1 vaccines
within the Cancer Vaccine Collaborative clinical
trials network
S.Gnjatic
Evaluation of the infl ammatory tumour infi ltrate
J.Talmagde
Standardization of T cell immunomonitoring - correct protocol
choices and additional sources of variation
C. Britten
Regulatory aspects
M. Schuessler-Lenz
The challenge of introducing new immunotherapy
K. Kallen
Round Table discussion |
| 7:30 p.m. |
Welcome Reception (Hotel Regent) |
| |
|
|
Wednesday | Thursday | Friday | Saturday
|